Effect of Shockwave Versus LLL Therapy on Sacroiliac Joint Pain in Postnatal Women

NCT ID: NCT05015413

Last Updated: 2021-11-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-11-25

Study Completion Date

2021-12-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Sacroiliac joint pain is the most causes of back pain In pregnancy caused ligament laxity in sacroiliac joint so cause pain and this pain continue after natal Shock wave is new conservative treatment used in physical therapy Shock wave is most effective for sacroiliac joint pain Low level laser is a most effective pain relive and effective on sacroiliac joint pain

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study is to determine if there is any difference between the effect of shockwave and low level laser therapy on sacroiliac joint pain in postnatal women This study will be randomly distributed into two equal group Group A consisted of 25 postpartum women complaining from sacroiliac joint pain . They will receive shockwave therapy 2 session per week for 6 weeks Group B consisted of 25 postpartum women complaining from sacroiliac joint pain . They will receive low level laser therapy 2 session per week for 6 weeks

Evaluation procedures History taking recording in recording data sheet Weight and height measurement by calculate BMI Disability assessment by OWDI Pain assessment by VAS scale Assessment of pressure of pain threshold by pressure algometry

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sacroiliac Joint Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Group A will receive shock wave therapy Group B will receive low level laser therapy
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

shock wave group

Group A will receive shockwave therapy 2 session per week for 6 weeks

Group Type EXPERIMENTAL

Shockwave

Intervention Type DEVICE

Shock wave master 500 Germany

low level laser group

Group B will receive low level laser therapy 2 session per week for 6 weeks

Group Type EXPERIMENTAL

Shockwave

Intervention Type DEVICE

Shock wave master 500 Germany

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Shockwave

Shock wave master 500 Germany

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* postnatal women suffering from sacroiliac joint pain for at least 3 months.
* They should have moderate to severe pain .
* They should have positive findings in at least 3 of 5 provocation sacroiliac joint tests

Exclusion Criteria

* lumber or hip joint pathology
* Acute pelvic bacterial or viral infection .
* Receiving corticosteroid injections within the previous 6 weeks
Minimum Eligible Age

25 Years

Maximum Eligible Age

40 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Samar Mimi Mohamed Okby

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Samar Mimi Mohamed Okby

Physical therapist in al Agoza police hospital

Responsibility Role SPONSOR_INVESTIGATOR

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Manal Ahmed El shafei, Doctoral

Role: CONTACT

Phone: 201220664518

Email: [email protected]

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

012/003237

Identifier Type: -

Identifier Source: org_study_id